Morbidity and mortality in patients on dialysis: the impact of hemoglobin levels.
Clinical reports supporting an association between hemoglobin (Hb) levels, morbidity, and mortality were a strong part of the dataset used by the National Kidney Foundation in recommending a target Hb level of 11 to 12 g/dL in patients on dialysis. This article provides an overview of the potential link between Hb correction and improvements in morbidity and mortality in patients on dialysis.
Fresenius Medical Care, San Diego, CA, USA.
Mary
M
Brattich
D000740:Anemia / Q000097:blood / Q000453:epidemiology / Q000209:etiology / Q000517:prevention & control*; D002423:Cause of Death; D006454:Hemoglobins / Q000378:metabolism*; D006760:Hospitalization / Q000706:statistics & numerical data; D006801:Humans; D007676:Kidney Failure, Chronic / Q000150:complications / Q000401:mortality / Q000628:therapy; D007902:Length of Stay / Q000706:statistics & numerical data; D009017:Morbidity; D017063:Outcome Assessment, Health Care; D006435:Renal Dialysis / Q000009:adverse effects* / Q000401:mortality; D012189:Retrospective Studies; D012307:Risk Factors; D016019:Survival Analysis; D013997:Time Factors
D006454:Hemoglobins